SUMMARY-Early stages of mammary tumors (EMT) were induced with a combined treatment of progesterone (P) and estrone (E) in ovariectomized adult GRStA (GR) mice, astrain of European origin and with a high incidence of mammary cancer. The mammary tumors were comparable to the pregnancy-dependent tumors of breeding females of this strain. The hormone treatment did not lead to EMT in a variety of other strains and only occasionally in the RIII and C3H strains. Treatment with P or E alone did not lead to EMT in GR mice, but treatment with the steroid eompound 17a-ethynyl-19-nortestosterone (ANT) did mimic the combined effeet of P and E. Since EMT could be induced by ANT in all ovariectomized adult GR mice within 3 weeks, this tumor-induction method was suitable for analysis of the gene responsible for palpable, pregnaney-dependent mammary tumors of this strain. Another argument for the usefulness of this test for genetic analysis was the fact that, though mouse mammary tumor virus (MuMTV) of the GR strain was introduced into BALBte and MAS miee by foster-nursing, ANT treatment did not lead to EMT. First and second backeross analyses showed that one gene was responsible for EMT induction. There was a strong correlation between the presence of EMT and MuMTV antigens in the mammary glands and milk of several first backeross populations between GR and other strains such as C57BL, BALBtc, DBAf, and C3Hf. This suggested that the expression of MuMTV antigens was also controlled by the EMT gene. Two types of resistance phenomena were observed. Neither type could prevent EMT after hormone treatment; however, they could delay EMT development. One resistance factor for EMT induction was noticeable and dominant in reciprocal hybrids of the GR and DBAf strains, whereas another resistance factor was detected in the backeross population only [l.e., in the C57BL X (C57BL X GR) backeross] and not in hybrids; therefore, this factor was recessive. Until now, linkage experiments with 18 markers to locate the gene for EMT induction in the map of the mouse were unsuccessful.-J Natl Cancer Inst 56: 27-32, 1976. 
Hormone-dependent mammary tumors appear in breeding female GRS/A (GR) mice at a very early age. In (1), Van Nie and Dux reported small mammary tumors in 18 of 23 GR mice killed at parturition; tumors were easily palpable later in life. Comparable hormonedependent mammary tumors can be induced in ovariectomized GR mice with a combined treatment of progesterone (P) and estrone (E). Palpable mammary tumors with an average diarneter of 8 mm could be induced in all GR mice after an 11.4-week mean treatment period (Van Nie R: Unpublished resuIts). The early stages of these hormone-dependent mammary tumors (EMT) are recognizable with a dissecting microscope after a 3-week treatment.
The genetic control of the susceptibility to hormonedependent mammary tumors in breeding females of the GR strain was studied extensively by Bentvelzen (2) , who demonstrated that a single dominant gene was responsible for mammary tumors in this strain of Europe an origin and wi th a high incidence of mammary cancer (3) . Furthermore, Bentvelzen showed the striking correlation between the occurrence of mammary tumors and the presence of infectious murine mammary tumor virus (MuMTV) in backcross animals of the GR strain and in C57BL/LiA mice, astrain with a low incidence of mammary cancer. Thus breeding females of the backcross that transmit MuMTV through their milk to newborn, virus-free susceptible miee developed mammary tumors, whereas animals of the same backcross that did not transmit infectious virus did not develop tumors.
Following up these findings, we decided 1) to develop a faster test for mammary tumors to speed up analysis of this gene, and 2) to develop immunologie tests for a rapid detection of M uMTV antigens rather than use the time-consuming virus test of foster-nursing.
MATERIALS AND METHODS
M ice.-All mice, except the linkage stocks, were from the breeding colony of the Netherlands Cancer Institute. Strains with a high incidence of mammary cancer include GRS/A (GR), RIII/SeA (RHI), DBA/LiA (DBA), and BALB/c/He/fA (BALB/cfC3H). Strains with a low incidence of mammary cancer include C57BLjLiA (C57BL), C57BL/IOjJA (BIO), BALBjcjHeA (BALBjc), CBAjBrA (CBA), DBA/Li/fA (DBAf), C3H/He/fA (C3Hf), 020A, (020), OIRjA (OIR), RIIIjSejfA (RUH), WLL / Br I eBA (WLLf), I. TS / fA (I. TSf), A / Br/ fA (Af), AKR/FuRdA (AKR), and MAS / A (MAS).
OIR is a partly congenic 020 strain with the H-2 q locus of the DBAf strain. For linkage experirnents, miee of so-called linkage stocks were purchased from The Jackson Laboratory, Bar Harbor, Maine. These markers are maintained on a C57BL/6 (B6) background and in backcrosses of the C57BL X GR hybrid to these B6 mice; the designation "BI." was used for both C57BL substrains. Markers on the B6 strain used in these experiments include: Si (Steel), Sd (Danforth's short tail), Ra (ragged), Ca (caracul), Re (rex), Pt (pintail), Mi w h (white), Wv (viable dominant spotting), Os (oligosyndactylism), and T (brachyury).
Three isozyme markers, serum esterase-l (Es-I), serum esterase-3 (Es-3), and malic enzyme (Mod-I), were determined by Dr. H. Hoffman, National Cancer Institute, Bethesda, Maryland, Dr. A. Dux, Department of Biology of the Netherlands Cancer Institute, determined the H-2 alleles (serologically) in the (BI. X GR)F 2 cross.
EMT induction.-Hormone treatment was started on the day of ovariectomy. E was given in the drinking water at a dosage of 0.5 mg per liter. P was administered in three pellets of 2.8 mg each, implanted se onee a week in the neck. The synthetic steroid hormone 17a-ethynyl-19-nortestosterone (ANT) was also given as a 2.7-mg pellet once a week. After the mice were kiIled, skins with mammary glands were detached and examined with a dissecting microscope for EMT. Some resuIts were statistically assessed by the chi-square test.
Immunofluorescence (IF) test on acetone-fixed mammary gland preparations.-The indirect IF test on acetone-fixed cells was used to show the presence or absence of MuMTV antigens in the cytoplasm of mammary gland ceIls, as described in (4, 5) . Mammary glands (with or without EMT) were trypsinized thoroughly with a mixture of 2.5% Bacto-trypsin, 0.25% collagenase, and 0.025'% DNase in ca1cium-magnesium-free Earle's balanced salt solution (EBSS). This treatment resulted in single cells (mainly stroma ceIls) and cell clumps of alveolar and ductal mammary gland structures. The mixture of single cells and cell c1umps was fixed with acetone for 10 minutes at room temperature, and the IF test was performed with rabbit antiserum against M uMTV [provided by Dr. Ph. Hageman, Department of Biology, Netherlands Cancer Institute, as described in (6) ] and absorbed in vivo in a MuMTVnegative mouse. In all tests, the absorbed antiserum was diluted until it reached the end point of fluorescence on positive control cells. The combination of in vivo absorption and subsequent dilution of the antiserum resulted in J\!I uMTV-specific fluorescence in the dilution range of 1/8-1/512.
Cytotoxicity absorption (CYTA) test on mammary gland extracts.-For CYTA tests, a 25% wet-weight suspension in EBSS was prepared from minced (but not trypsinized), normal tissue of the hormone-stimulated mammary glands; the cell suspension plus cell c1umps were diluted twofold. One volume of the appropriate dilution of the in vivo and in vitro (with BALB/c-milk) absorbed rabbit antiserum against MuMTV [one tW9-fold dilution above the dilution that kills 50% of the MuMTV antigen-positive target ceIls, i.e., GRSL2 cells (7)] was then added to one volume of the twofold diluted tissue suspension. The decrease of cytotoxicity was measured in a conventional cytotoxicity test with the use of trypan blue. The M uMTV cell-surface antigen detectable by this system is caIled MLr (7) .
Immunodiffusion (ID) test with milk.-ID tests were performed on 2% Noble's agar slides (ImmunopIate pattern type C; Hyland Laboratories, Los Angeles, Calif.). The slides were left at room temperature in a humidified chamber for approximately 24 hours. Rabbit serum against MuMTV and milk were applied in undiluted form. Generally, one c1ear precipitation Iine was observed, presumably presenting the MuMTV-sl antigen (8) as weIl as some weaker lines. The antigen or antigen complex is called the MuMTV-gs antigen, because this line can be observed with aIl :MuMTV strains tested so far. The antiserum was absorbed in vitro with 15 mg Iyophilized milk powder of BALB / c mice / ml. This absorption was sufficient to remove nonspecific precipitation.
Milk from the first or second lactation periods was used for the ID tests. Thus in case of EMT induction in ID-tested animals, ovariectomies were performed after one or two pregnancies.
RESULTS
EMT could be induced with a combined hormone treatment of P and E in ovariectomized adult GR mice. Table 1 shows that a 9-day treatment with P pellets and E in the drinking water induced EMT in some animals, whereas after a 21-day treatment, aIl mice developed tumors. The size of the EMT's, as weIl as the average number per mouse increased after prolonged hormone stimulation.
A variable in the efficiency with which these tumors could be induced was by the age of the mouse at ovariectomy. Table 2 shows that the treatment was equally efficient in adult mice of various ages (8, (12) (13) 16 , and 25 wk), but was less efficient in 3-week-old mice.
The hormone dependency of El\IT was studied in 18 GR mice that had been ovariectomized at 13 weeks of age and were subsequently treated with P plus E for 3 weeks. The hormone treatment was terminated and the mice were killed 6 weeks later. Since no EJ\!IT were found in these mice, it may be conc1uded that the EMT present at the end of the treatment had regressed after termination of the treatment. Thus the EJ\!IT are hormone dependent.
P or E treatment alone did not lead to EMT, but treatment with the steroid compound ANT could mimic the combined effect of P and E. Table 3 shows the effect of this synthetic hormone, which exerts a pronounced progestational activity combined with a relatively low estrogenicity. Virgin mice did not develop EMT spontaneously. The GR strain is unique in its response to treatment with P and E. Table 4 shows that this treatment never led to EMT in strains C3H and BALB / cfC3H with a high incidence of mammary cancer and strains BALB / c and CBA wi th a low incidence of mammary cancer, whereas very few EMT were induced in RH! mice, another strain with a high incidence of mammary cancer. The GR strain is also unique in its response to ANT. Table 5 shows that a11 treated GR mice developed EMT. Thus C57BL, BIO, DBA, DBAf, and 020 strain mice did not develop EMT, whereas a few EMT were found in C3H and RHI mice. ANT treatment for 5 weeks led to a substantial incidence of EMT in RII! mice, whereas the same prolonged hormone stimulation did not lead to EMT in RIIIf mice; this indicated a milk factor influence. The average number of EMT in positive RHI mice was much lower than in GR mice. Table 6 shows the relatively small influence of the milk factor of the GR strain on induction by EMT hormones. Hence foster-nursed G R mice still developed EMT after a 3-week treatrnent with ANT, whereas mice from susceptible strains BALB j c and MAS with a low incidence of cancer, after being Ioster-nursed by GR mothers, did not develop EMT or did so only occasionally, even after prolonged treatment with the hormone. As seen in table 7 7 3-week ANT treatment of hybrids between the GR strain and strains with high and low incidences of mammary cancer led to EMT in virtually 100% of the animals. DBA X GR and its reciprocal hybrids were relatively resistant in terms of number of EMT per mouse, whereas all other hybrids (with C57BL, BALBjc, C3Hf, OIR, 020, RUH, WLLf, LTSf, Af, and AKR) were approximately equally susceptible.
Treatment of segregating crosses between GR mice and other strains such as C57BL, DBAf, and C3Hf led to EMT in approximately 50% of the animals, even after a prolonged hormone stimulus up to 7 weeks. One exception was the DBAf X (DBA X GR) backeross, because a 3-week treatment, unlike a 5-week treatment, was not sufficient to reach the 50% level. In fact, this would be expected on the basis of the relative resistance of the (DBM X GR)F 1 (table 8). None of the percentages reported for these backcrosses, except the 28% after 3 weeks of hormone treatment in the DBM X (DBAf X GR), was significantly different from the expected 1: 1 ratio as calculated by the chi-square test and based on the one-gene hypothesis. Table 9 shows the number of mice with various amounts of EMT after a 3-week treatment with ANT in the GR mouse, the (C57BL X GR) F 1 and the C57BL X (C57BL X GR) backcross. The average number of EMT in the backeross was significantly lower than in the hybrid and the GRstrain; this indicated a slight but definite recessive resistance trait for EMT development in the C57BL strain. Since this trait is not detectable in the FlJ it must be different from the resistance factor of the DBAf strain.
EMT induction by ANT in segregating populations of a GR hybrid to several strains with low incidence of mammary tumors (such as C57BL, BALBjc, C3Hf, and DBAf) correlated with MuMTV antigen expression in mammary glands and milk (table 10). Several Immunologie techniques were utilized to show this correlation, such as an IF test on acetone-fixed cell preparations of mammary glands, a CYTA test in mammary glands extracts for a MuMTV-induced cell-surface antigen, and an ID test for MuMTV antigens in the milk.
The total number of EMT-positive mice was 84 and that of negative mice was also 84, a ratio in line with the one-gene hypothesis for induction of these tumors, For MuMTV antigen expression, these numbers were 90 and 78, respectively; this is again consistent with a onegene hypothesis for expression of the MuMTV antigen. In all crosses, with the use of three techniques for antigen detection, there appeared to be a linkage between these two genes. The total number of disconcordant extracts or milks was 12 of 168.
As a further test of the one-gene hypothesis for EMT induction, MuMTV expression, andthe possibility of linkage, second backeross typing was done; the results of the progeny testing are in table 11. Of 13 first backcross BALB/c X (BALB/c X GR) females, 41 second backcross daughters were tested for EMT after ANT treatment. This resulted in 17 animals with and 24 animals --220 (25.5) (25.9) (20.5) (11.4) (10.0) (2.7) (1.8) (0.9) (0.5) (0.5) (0.5)
• Va.lues in parenthllBIlB are percents of mice with EMT. Treatment of ovariectomized adult GR mice with ANT, a compound with progestational activity combined with a relatively low estrogenicity (9, 10) , most effectively induced mammary tumors. A 3-week treatment was sufficient to induce EMT in all GR mice. Since the occurrence of pregnancy-dependent, palpable mammary tumors in this strain was controlled by a single gene (2) and analysis of the action 01 this gene was our main interest, it was irnportant to study the relationship between the genetic control of these palpable tumors in mice less than I year of age and the EMT that could be induced within 3 weeks in castrated virgins.
The results essentia11y agree with those of Bentvelzen (2), e.g., on the incidence of palpable tumors in backcrosses between GR and strains with low incidence of mammary cancer, such as BALBjc, C3Hf, DBAf, 020, and C57BL. In such crosses, the incidence of palpable mammary tumors was approximately 50% before mice were 1 year of age, indicating a one-gene control that was proven correct by progeny typing.
Milk transmission of GR-MuMTV in otherwise susceptible BALB/c and MAS mice leads only occasiona11y to EMT, which makes this test suitable for genetic purposes. In contrast, up to 100% of palpable mammary tumors can be induced in BALBjc mice before I year of age and after foster-nursing by GR mothers. Even mice of more resistant strains such C3Hf, DBAf, 020, and C57BL will develop some mammary tumors before 1 year of age after foster-nursing (2) .
Nandi and Helmich (11) reported a 73% incidence of mammary tumors in rhe [(GR X BALBjc) X er BALB/c] foster-nursed BALB/c backcross at I year of age, whereas 53a~J occurred at 7 months of age. All tumors in the GR and (BALBjc X GR)F 1 also occurred at 7 months of age. It can be argued that the 53% of tumors at 7 months represent the EMT reported here and can be controlled by the same dominant gene, whereas the additional tumors between 7-12 months might be caused by another gene that is not demonstrated yet by our work or the work of Bentvelzen (2) . The late tumor group under control of a second gene might represent another tumor type, such as the neoplasms originating from the non-horrnone-dependent nodules which are not hormone-dependent and which occur in the GR strain.
Since a11 animals of the backcrosses in (11) that developed tumors later in life also transmitted MuMTV with their milk to susceptible offspring, the authors claim the without EMT, a figure close to the expected 1: 1 ratio. Of 9 negative first backcross fernales, 29 daughters were a11 negative except 2. It appeared later that these 2 were daughters of I mother that was positive by the ID test for l\I uMTV-gs antigen in the milk. Thus this first backcross animal might have been one in which EMT development was missed. The results of the progeny typing in the second backcross were compatible with a one-gene hypothesis for EMT inducrion that was strongly indicative of a one-gene control for MuMTV-antigen expression bccause of the correlation in the first backerosses. Table 12 depicts the preliminary atternpts to locate the EMT gene and possibly the gene for MuMTV antigen expression on the linkage map of the mouse. Until now, no linkage has been found. The markers used in-
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H-2fJRH-2fJR 14 3 o Expected ratio =1 : I. b Expected ratio =3: 1. existenee of two independent genes for tumor induetion and MuMTV transmission. Although this eould not be eonfirmed in this study with the use of relatively insensitive immunologie assays sueh as ID, IF, and CYTA tests, reeent unpublished evidenee in work done at our Institute and obtained with the very sensitive radioimmunoassay developed by Verstraeten et al. (12) indieated that more than 50% of the baekerosses were MuMTV antigen positive. This indieates the possible funetion of a seeond gene in the induetion of low levels of MuMTV as opposed to the high levels indueed by the first gene. However, in this partieular baekeross, extraehromosome transmission by the GR male eannot be ruled out (13) (14) (15) . Two types of resistanee against EMT induetion were diseovered: 1) a dominant trait delaying EMT induetion in (DBAf X GR) F 1 miee and 2) a reeessive trait delaying EMT induetion in C57BL X (C57BL X GR) baekcross mice, but not in (C57BL X GR)F 1 mice. The nature of the resistance factors are not understood yet, but one should consider that they might be different from H-2-related resistance toward exogenously administered MuMTV (16) . For example, if an H-2-related effect eauses DBAf resistance, one would expect that DIR, a congenic strain with the H-2 q locus of the DBA, shows the same resistance; however, this is not the case. The relative resistance of the DBAf strain might be related to the low and late expression of its endogeneous MuMTV; i.e., a genetie mechanism controlling this could possibly interfere with GR-MuMTV expression too. However, in this instance, one would expect a delay in the (C3Hf X GR)F 1 as well, but this was not observed.
The transmission of the MuMTV of the GR strain is probably controlled by the gene responsible for EMT development. Recent genetic studies showed that the transmission of the endogenous MuMTV in the C3Hf strain is controlled by another dominant gene (17) .
